Presentation TCT 2025 The Many Faces of MAC: Imaging Insights Guiding Therapy Presenter: Jonathon A. Leipsic October 28, 2025
Presentation TCT 2025 TCT 965: Can Machine Learning Aid the Evaluation of the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After PCI? Presenter: Hao-Yu Wang October 28, 2025
Presentation TCT 2025 TCT 1350: Prosthesis Embolization During Percutaneous Pulmonary Valve-in-Valve Implantation in Adult Tetralogy of Fallot Survivor Presenter: Maciej Skubera October 28, 2025
Presentation TCT 2025 EFS in the US is Back! What’s needed for EFS 2.0 to Maintain and Grow the Program? Presenter: Michael J. Mack October 28, 2025
Presentation TCT 2025 TCT 1487: Successful Atrial-Fixation TMVR Implantation via Left-Sided Access in Severe MAC Patient Presenter: Mamoo Nakamura October 28, 2025
Presentation TCT 2025 TCT 1488: Minimally Invasive Transatrial Direct Surgical Valve-in-MAC Implantation: How to Treat the Untreatable Presenter: Giuseppe Bruschi October 28, 2025
Presentation TCT 2025 TCT 1015: External Validation of the xDAPT Machine Learning Model for Ischemic and Bleeding Risk After Percutaneous Coronary Intervention Presenter: Davide Cao October 28, 2025
Presentation TCT 2025 Bioresorbable Scaffolds as a Preferred Treatment for Ruptured Plaques and Younger ACS Patients: Is It Still a Possibility? Presenter: Maciej Lesiak October 28, 2025
News Conference News TCT 2025 ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR Todd Neale October 27, 2025
News Conference News TCT 2025 Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC Yael L. Maxwell October 27, 2025
News Conference News TCT 2025 PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI Michael O'Riordan October 27, 2025
Presentation TCT 2025 TCT 916: Machine Learning to Predict Neurological Outcome after Out-of-hospital Cardiac Arrest Presenter: Johannes Michael Altstidl October 27, 2025
Presentation TCT 2025 TCT 1482: Successful Transcatheter Transseptal Implantation of an Aortic Bioprosthesis Into the Mitral Valve ("Valve-in-MAC") After Alcohol Septal Ablation Presenter: David Zemanek October 27, 2025
Presentation TCT 2025 TCT 1481: When Surgery Is Not an Option: Transcatheter Mitral Valve-in-MAC Replacement Presenter: Iulian Calin October 27, 2025
Presentation TCT 2025 TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES. Presenter: Robert T. Gerber October 27, 2025
Presentation TCT 2025 Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort Presenter: Paul Sorajja October 27, 2025
Presentation TCT 2025 Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes Presenter: Michael J. Mack October 27, 2025
Presentation TCT 2025 TCT 476: Synergistic Impact of Insulin Resistance and Hepatic Fibrosis on Cardiovascular Events in Patients with Coronary Artery Disease: A Machine Learning Subtyping and Interaction Analysis Presenter: Zhihao Zheng October 27, 2025